AQEMIA Achieves Research Milestone Against Undruggable Target in Immuno-Oncology with Servier
PARIS–(BUSINESS WIRE)– AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent...